{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:51:22Z","timestamp":1789588282845,"version":"build-2803163510"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138722","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T18:55:21Z","timestamp":1442602521000},"page":"e0138722","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach"],"prefix":"10.1371","volume":"10","author":[{"given":"Christoph","family":"Jindra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Shafti-Keramat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wolschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Ferko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Muster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kirnbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2010.10.002","article-title":"Persistence of human papillomavirus infection: keys to malignant progression","volume":"19","author":"J Bodily","year":"2011","journal-title":"Trends Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1529-8019.2010.01350.x","article-title":"An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention","volume":"23","author":"M Forcier","year":"2010","journal-title":"Dermatol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coi.2010.11.009","article-title":"Prevention of cancer by prophylactic human papillomavirus vaccines","volume":"23","author":"K Kwak","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1479-828X.2010.01269.x","article-title":"HPV infection and cervical disease: a review","volume":"51","author":"JR Carter","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1128\/JVI.68.9.5698-5705.1994","article-title":"The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest","volume":"68","author":"SA Foster","year":"1994","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/ijc.22064","article-title":"HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300","volume":"119","author":"MA James","year":"2006","journal-title":"Int J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1002\/j.1460-2075.1989.tb08594.x","article-title":"Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product","volume":"8","author":"K Munger","year":"1989","journal-title":"EMBO J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.3390\/cancers3033461","article-title":"New Approaches to Immunotherapy for HPV Associated Cancers","volume":"3","author":"AS Bergot","year":"2011","journal-title":"Cancers"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1128\/JVI.00190-12","article-title":"Attenuated influenza virus construct with enhanced hemagglutinin protein expression","volume":"86","author":"J Maamary","year":"2012","journal-title":"Journal of virology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"J Steel","year":"2009","journal-title":"Journal of virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2746\/042516408X371937","article-title":"Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses","volume":"41","author":"TM Chambers","year":"2009","journal-title":"Equine veterinary journal"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tube.2006.01.010","article-title":"Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein","volume":"86","author":"MA Stukova","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/CVI.00056-06","article-title":"Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge","volume":"13","author":"S Sereinig","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/514175","article-title":"Development of novel influenza virus vaccines and vectors","volume":"176","author":"P Palese","year":"1997","journal-title":"The Journal of infectious diseases"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/314445","article-title":"Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract","volume":"178","author":"B Ferko","year":"1998","journal-title":"The Journal of infectious diseases"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"BG Hale","year":"2008","journal-title":"J Gen Virol"},{"key":"ref17","first-page":"177","article-title":"Attenuated influenza virus vaccines with modified NS1 proteins","volume":"333","author":"JA Richt","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/649428","article-title":"A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1","volume":"201","author":"V Wacheck","year":"2010","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e5984","DOI":"10.1371\/journal.pone.0005984","article-title":"Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine","volume":"4","author":"J Romanova","year":"2009","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2004.03.035","article-title":"Rescue of influenza virus expressing GFP from the NS1 reading frame","volume":"324","author":"C Kittel","year":"2004","journal-title":"Virology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.75.19.8899-8908.2001","article-title":"Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice","volume":"75","author":"B Ferko","year":"2001","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11621","DOI":"10.1128\/JVI.01645-06","article-title":"Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts","volume":"80","author":"B Ferko","year":"2006","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"28399","DOI":"10.1074\/jbc.R110.149625","article-title":"Thematic minireview series: toward a structural basis for understanding influenza virus-host cell interactions","volume":"285","author":"CE Samuel","year":"2010","journal-title":"The Journal of biological chemistry"},{"key":"ref24","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"KY Lin","year":"1996","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1073\/pnas.95.4.1800","article-title":"Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model","volume":"95","author":"HL Greenstone","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e116389","DOI":"10.1371\/journal.pone.0116389","article-title":"Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer","volume":"10","author":"S Peng","year":"2015","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: aresults from the I-MOVE multicentre case-control study","volume":"18","author":"E Kissling","year":"2013","journal-title":"Eurosurveillance"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.1998.9508","article-title":"Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems","volume":"252","author":"A Garcia-Sastre","year":"1998","journal-title":"Virology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.09.76","article-title":"Therapeutic HPV DNA vaccines","volume":"8","author":"A Monie","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14712598.8.4.421","article-title":"Therapeutic human papillomavirus vaccines: current clinical trials and future directions","volume":"8","author":"CF Hung","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e4122","DOI":"10.1371\/journal.pone.0004122","article-title":"Influenza a virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells","volume":"4","author":"S Sturlan","year":"2009","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archpediatrics.2010.203","article-title":"Children hospitalized with 2009 novel influenza A(H1N1) in California","volume":"164","author":"JK Louie","year":"2010","journal-title":"Archives of pediatrics & adolescent medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/JVI.80.1.383-394.2006","article-title":"Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells","volume":"80","author":"CL Efferson","year":"2006","journal-title":"Journal of virology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00430-009-0139-0","article-title":"Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells","volume":"199","author":"H Ogbomo","year":"2010","journal-title":"Medical microbiology and immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e36506","DOI":"10.1371\/journal.pone.0036506","article-title":"Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame","volume":"7","author":"M van Rikxoort","year":"2012","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1128\/JVI.70.8.5519-5524.1996","article-title":"African Green Monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B","volume":"70","author":"EA Govorkova","year":"1996","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10559","DOI":"10.1128\/JVI.76.20.10559-10568.2002","article-title":"Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells","volume":"76","author":"AM Helt","year":"2002","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1128\/JVI.77.12.6957-6964.2003","article-title":"The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo","volume":"77","author":"ML Nguyen","year":"2003","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.1128\/JVI.00169-11","article-title":"Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture","volume":"85","author":"E Roethl","year":"2011","journal-title":"Journal of virology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JVI.01650-10","article-title":"Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency","volume":"85","author":"M Wolschek","year":"2011","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"R Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1128\/JVI.01088-09","article-title":"Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines","volume":"83","author":"C Schellenbacher","year":"2009","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells","volume":"23","author":"MC Feltkamp","year":"1993","journal-title":"Eur J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/vim.1999.12.297","article-title":"T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16","volume":"12","author":"R Azoury-Ziadeh","year":"1999","journal-title":"Viral Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1743-422X-8-59","article-title":"A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection","volume":"8","author":"A Monroy-Garcia","year":"2011","journal-title":"Virol J"},{"issue":"Pt 1","key":"ref46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1099\/0022-1317-75-1-157","article-title":"Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector","volume":"75","author":"L Gao","year":"1994","journal-title":"J Gen Virol"},{"issue":"Pt 6","key":"ref47","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1099\/0022-1317-71-6-1347","article-title":"Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein","volume":"71","author":"RW Tindle","year":"1990","journal-title":"J Gen Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/027245701753179848","article-title":"Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV","volume":"20","author":"AP Wlazlo","year":"2001","journal-title":"Hybridoma"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0143269","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T13:08:23Z","timestamp":1599570503000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138722"}},"subtitle":[],"editor":[{"given":"Sang-Moo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138722","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0143269","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}